Gene editing techniques at Christiana Care Health System have been proven to cut cancer diagnosis times in half and are being commercialized for worldwide use. Listen to this story. Christiana Care received a $1 million Binational Industrial Research and Development (BIRD) grant just over a year ago to try to reduce the time it takes […]

AMS Bio has introduced new CRISPR/Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications. The latest tool in genome science, CRISPR/Cas9 is a simple and efficient genome editing tool that allows for specific genome disruption and replacement resulting in high specificity and low cell toxicity. AMS Bio CRISPR Complete kits are tailor-made for specific projects […]

Investing in the stock market will always come with ups and downs. There are so many different factors that can have an impact on the day to day movements of stock prices. Finding the correct investing strategy may take some time. Many investors may have the tendency to become impatient when the portfolio is not […]

NEW YORK (GenomeWeb) – When gene-editing technology company Inscripta announced last December that it was releasing a new CRISPR enzyme it had created free of charge to the research community, the response was “overwhelming,” according to CEO Kevin Ness. Get the full story withGenomeWeb Premium Only $95 for thefirst 90 days* GenomeWeb Premium gives you:✔ […]

A scientist preparing DNA samplesPhoto: USFWS Northeast (Flickr) Scientists and biotechnologists have heralded the CRISPR-Cas9 gene editing system as revolutionary way to edit DNA, like scissors and a glue stick for the genome. But a new study found some potentially harmful unintended effects. This isn’t the first time a paper has found flaws in CRISPR’s abilities, […]

In light of the recent statement made by  US Food and Drug Administration (FDA)’s Commissioner, Scott Gottlieb, MD, regarding the new guidance documents for gene therapy development, the rare disease community is buzzing. Researchers working with rare diseases that have genetic origins are increasingly turning to the use of these therapies as potential treatment options. […]

Typically, there’s a clear distinction between a manufacturer/end-user firm and a packaging supplier. That not necessarily the case in CRISPR development where Millipore Sigma serves as just such an example. Formed in 2015 when EMD Millipore combined with Sigma-Aldrich, MilliporeSigma operates in the U.S. and Canada. It produces more than 300,000 products that include gene-editing […]

Bilibili Inc. (NASDAQ:BILI) popped in on a high volume red day. Volume on 17-Jul-18 came in at 6.83 million contracts. The daily trading volume has averaged 5.46 million shares a day in past 3 months. The first sale was made at $13.42 but later the stock became weaker, and closed with a fall of -0.8%. […]

The National Academies of Sciences, Engineering, and Medicine on Wednesday released a report on how to address the most pressing problems of American agriculture. The list of those problems is long and scary: climate change, food waste, water scarcity, food-borne illness, pests, and disease. “Agriculture is confronting a crisis no less epic than the dustbowl […]

A CRISPR patent owned by the Broad Institute of Harvard and MIT is “unpatentable for indefiniteness”, according to an agriculture biotech company. Benson Hill Biosystems filed a petition for a post-grant review (PGR) of the patent, which is licensed to Editas Medicine, at the US Patent and Trademark Office (USPTO) on Tuesday, July 17. Broad’s […]